Clinical Trial Results: Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial results for Epetraborole in treatment-refractory MAC lung disease have been posted after termination of the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mac Lung Disease
• Mycobacterium Avium Complex Lung Disease

Drugs mentioned

• Epetraborole (epetraborole)

Snippet

Sponsor: AN2 Therapeutics, Inc | Conditions: MAC Lung Disease, Treatment Refractory MAC Lung Disease | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2026-06-10